Remove Genetics Remove Radiology Remove Research
article thumbnail

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’

pharmaphorum

Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The post Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’ appeared first on.

Genetics 136
article thumbnail

World Cancer Day 2024: Trends in Oncology Research and More

XTalks

Technological advancements are revolutionizing cancer research and therapies. By editing these genes, researchers can effectively neutralize their cancer-promoting effects. By tailoring treatments based on an individual’s genetic makeup, it may allow for more effective and targeted therapies.

Research 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Small glowing protein allows researchers to peer deeper into living tissues

Medical Xpress

Biomedical and genetic engineers at Duke University and the Albert Einstein College of Medicine have designed a small fluorescent protein that emits and absorbs light that penetrates deep into biological tissue.

Protein 75
article thumbnail

Patient Safety and Radiopharmaceuticals Administration: Minimizing Radiation Exposure and Risks

Worldwide Clinical Trials

Genetic Factors : Certain genetic mutations, such as those in DNA repair genes, can affect how cells respond to radiation. International Commission on Radiological Protection (ICRP) The ICRP provides recommendations and guidance on radiation protection standards for occupational and public exposure.

Hormones 130
article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law Blog

Peter Marks and Patrizia Cavazzoni, spans across both Centers, and will collaborate with the Center for Devices and Radiological Health, Oncology Center of Excellence, Office of Orphan Products Development, and Office of Combination Products. those reviewed by the CDER Division of Rare Diseases and Medical Genetics).

article thumbnail

Wood-Fired Cooking a Cause of Lung Illness in Developing World

The Pharma Data

Researchers studied the impact of cookstove pollutants on 23 people in Thanjavur, India, who use liquefied petroleum gas or wood biomass (wood, crop waste or wood brush) to cook. There may be a genetic predisposition for some individuals to be more susceptible to their environment, Kizhakke Puliyakote said. THURSDAY, Nov.

article thumbnail

AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray modelling AI; UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3

Delveinsight

That disparity that startled the researchers running the trials has been the topic of debate since AstraZeneca shared the top-line data. The two-dose efficacy figure covers divergent results between subjects who commenced on a half dose and those that got two full doses. The efficacy of the 2,741-subject half-dose primer arm was 90%.